Skip to main content
Completion requirements

AI-based projects in healthcare must align with the Regulation (EU) 2017/745 on medical devices (MDR) and the Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR) to ensure patient safety, performance reliability, and compliance with European legal standards. According to the Medical Device Coordination Group (MDCG) 2019-11 Guidance, AI software intended for medical purposes—including diagnosis, monitoring, and treatment—qualifies as a medical device and is subject to strict classification based on its risk level. High-risk AI applications, such as automated diagnostic tools, require conformity assessments and clinical validation to meet the General Safety and Performance Requirements (GSPR) of the MDR.

Additionally, Directive 2016/1148 on security of network and information systems (NIS Directive) and MDCG 2019-16 Rev.1 Guidance on Cybersecurity for Medical Devices establish mandatory cybersecurity measures to protect AI-based medical devices against cyber threats and unauthorized alterations. These regulations require a privacy-by-design approach, ensuring strong data governance, secure encryption, and comprehensive traceability of AI decisions to safeguard from unauthorized access or system manipulation.

In compliance with the MDR, AI developers must also ensure transparency and explainability, particularly for high-risk AI models. Systems must provide sufficient documentation and justification for their outputs, allowing healthcare professionals to interpret AI-generated decisions. Adherence to these regulations is essential to maintain trustworthiness, accountability, and ethical compliance in AI-driven healthcare solutions.

Cancer Image Europe is a research infrastructure established by the EUCAIM project, a flagship action of the European Cancer Imaging Initiative.

This project is co-funded by the European Union under Grant Agreement 101100633. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Commission. Neither the European Union nor the granting authority can be held responsible for them.

© 2025, European Federation for Cancer Images (EUCAIM) Project Consortium. All Rights Reserved.